deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01838863

Control of Major Bleeding After Trauma Study (COMBAT)

A Prospective, Randomized Comparison of Fresh Frozen Plasma Versus Standard Crystalloid Intravenous Fluid as Initial Resuscitation Fluid

Sponsor: Denver Health and Hospital Authority

Conditions Hemorrhagic Shock Trauma
Interventions Crystalloid fluid (standard of care for resuscitation) Type AB plasma
Updated 13 times since 2017 Last updated: Dec 15, 2018 Started: Apr 7, 2014 Primary completion: Apr 3, 2017 Completion: Apr 3, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Futility

Other terminated trials from Denver Health and Hospital Authority

See all terminations from Denver Health and Hospital Authority

Other Hemorrhagic Shock trials with similar outcome

Browse all Hemorrhagic Shock trials

A PHASE2 clinical study on Hemorrhagic Shock and Trauma, this trial is terminated or withdrawn. The trial is conducted by Denver Health and Hospital Authority and has accumulated 13 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Mar 2018 · 10 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 8 earlier versions

  1. Aug 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  2. Feb 2019 — Aug 2019 [monthly]

    Terminated PHASE2

  3. Aug 2018 — Feb 2019 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Aug 2018 [monthly]

    Terminated PHASE2

  5. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  6. May 2017 — Mar 2018 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  7. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Denver Health and Hospital Authority
  • U.S. Army Medical Research and Development Command
  • University of Colorado, Denver
Data source: Denver Health and Hospital Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations